|
hTEE Symposium
October 14
 (Click to learn more)
Are You Attending the ESICM Congress in Lisbon? If so, let us know if you are interested in joining a dozen esteemed physicians on the evening of October 14 as they discuss their experience with hTEE. Space is limited, so please RSVP now to press@imacorinc.com!
|
Conference
Participation SOCCA 25th Annual Meeting October 11-12 Washington, DC, USA   ASA Annual Meeting
October 13-17
Washington, DC, USA
25th Annual Congress of the ESICM
October 13-17
Lisbon, Portugal
|
Testimonial
"It is exciting to be on the cutting edge, to be the first hospital in the state of Georgia that understands how important it is to fully integrate ultrasound capabilities into the critical care setting.
The ClariTEE® probe and Zura EVO™ imaging platform enable gold standard hemodynamic assessment easily, and over time."
Dennis Ashley MD
Director of Trauma Services
The Medical Center of Central Georgia
|
 | | Maung Haing MD, a fellow at NYP Hospital - Columbia training on simulator with Kathie McEnaney RDCS RDMS, ImaCor |
|
 | | Erika Wilkman MD working with Tero Varpula MD PhD from Meilahti Hospital Finland on probe handling and image acquisition |
|
 | | Meeting with participants at the HAI Conference in Berlin, Germany |
|
 | | Physician meeting with ImaCor CEO Peter Pellerito (right) and European Sales Director Cor Jongen (center) at the HAI Conference |
|
Social Media
We would like your help to better understand how to engage with you on social media. Would you take 30 seconds to answer these five questions?
|
|
_____________________
Friend Us on Facebook
|
Contact Us www.imacorinc.com info@imacorinc.com 1.877.244.0657 |
Contributions Should you wish to submit an article to our next monthly newsletter, please contact Sheila McGarrigle at newsletter@imacorinc.com
|
|
|
|
Video Case Discussion: Hitoshi Hirose MD
Thomas Jefferson University Hospital
| |
|
A Fellows Review at the
Hospital of the University of Pennsylvania (HUP)
"My first experience with the ImaCor probe at Penn was with Benjamin Kohl MD in the CTICU. He was making fine adjustments to the RVAD and LVAD speeds of a patient in cardiogenic shock. It was exciting to see him decrease the RPMs of the patient's RVAD, increase the epinephrine, and see in real time whether the septum bulged into the LV. We could return a few hours later to see on echo how the patient was tolerating the changes that we made, and further challenge the patient if appropriate."
Clare H. Ridley MD
Fellow, Cardiac Anesthesiology
Department of Anesthesiology & Critical Care
University of Pennsylvania
Perelman School of Medicine
"The concept of utilizing focus-assessed transthoracic echocardiography (FATE or TTE) for hemodynamic management of patients in the ICU has been reported in the literature for quite some time now. Patients who require echocardiography for complex hemodynamic management may not be amenable to meaningful serial TTE examinations and therefore require transesophageal echocardiography (TEE). Using a small, indwelling TEE probe has personally proven to be quite useful in providing continuous evaluation of cardiac function in the setting of complex hemodynamic management."
Kam Ghadimi MD
Fellow, Adult Critical Care, Cardiothoracic & Vascular Anesthesiology
Department of Anesthesiology & Critical Care
University of Pennsylvania
Perelman School of Medicine
|
|
Top 10 Journal Articles on hTEE
(in my humble opinion)
|
 Simulator-Based Training
 In our August newsletter we featured the hTEE Reading Room as a key component of our physician education and training program. Another cornerstone of that foundation is our HeartWorks (London, UK) hTEE simulator.
ImaCor is the only ultrasound manufacturer that offers these state-of-the-art 3D, interactive simulators to customers as a value added service and part of our onsite training package. As the operator inserts, withdraws, rotate or flexes the ClariTEE probe, the corresponding movements are displayed on the computer screen. The left side of the screen shows a beating image of the heart and the right side shows the corresponding echo image.
"The HeartWorks simulators are exquisitely detailed in the anatomy and function they display," says Scott Roth MD and Chief Medical Officer of ImaCor. "They have become an invaluable tool in training intensivists to perform the hTEE exam."
|
 Highlights from Chicago (American College of Surgeons Congress, October 1-4, 2012)
Harold M. Hastings, Co-Founder and CTO
Here are two highlights from the American College of Surgeons meeting concluding today in Chicago. First, Daniel Shouhed MD (and a team from Cedars Sinai Medical center, Los Angeles, CA) spoke on "Flow Disruptions during Trauma Care" in a session on quality and outcomes. No, he did mot mean blood flow, which is clearly important, but rather workflow. One source of workflow disruptions is lack of on-demand imaging - Dr. Shouhed cited CT, but his message could apply equally well to TEE. Second, D. Benjamin ("Benji") Christie MD (and a team from the Medical College of Central Georgia, Macon, GA) presented a video "Surgeon-Performed Ultrasound in the ICU: An Extension of the Physical Exam". One takeaway is the use of the miniaturized ImaCor hTEE probe to provide episodic on-demand TEE for hemodynamic assessment and management. The video will be available shortly from the American College of Surgeons; look for a link in our next issue. In conclusion, ImaCor has made TEE available on-demand to surgeons (and intensivists and other ICU personnel), aimed at helping with both management and workflow challenges faced daily in trauma and acute care surgery.
|
|
ImaCor continues to drive clinical impact and cost reduction through hTEE technology around the world. On October 14th in Lisbon a dozen distinguished physicians, including Drs. Michael Pinsky of UPMC, Jan Bakker of Erasmus, and Antoine Vieillard-Baron of Ambroise Paré, will speak to their experience and studies using hTEE. We are expecting an exceptional academic evening, and look forward to sharing with you the posters and video presented during this event.
We value your candid feedback on hTEE as it captures the unique challenges in intensive care. We understand mounting cost pressure in ICU's, where 20% of the patients disproportionately impact 80% of available resources. Our clinical partners continue to show us how to improve ICU effectiveness through optimal patient selection and 'protocolizing' the hTEE application for these complex patients.
With hTEE, you can also reduce the need for costly therapies like Nitric Oxide (NO) and associated invasive monitoring devices. We are learning that, because of hTEE, you have better information for hemodynamic management to help you mitigate the risk and cost of using such therapies.
Scott L. Roth MD, our Chief Medical Officer, continues to guide these and other related clinical activities. Please feel free to reach out to Scott at CMO@imacorinc.com or me at Peter@imacorinc.com to share with us your experience using hTEE. We welcome your feedback.
And finally a note on our growth as an organization. Here at ImaCor we have made some strategic new hires to focus on key initiatives for our company. I welcome Cor Jongen, our European Director of Sales and Marketing, and Michael Burns, our Director of Clinical Operations. Cor will expand our presence in Europe, and Michael will provide leadership on building out our clinical team and onsite educational initiatives. I also welcome Lori Romanetti RDCS RDMS, and Kathie McEnaney RDCS RDMS who will be working with Michael Burns in the clinical specialist capacity.
The ImaCor team is committed to driving clinical efficacy and reducing the cost of intensive care. We trust you will experience these benefits with our New Technology Assessment (NTA) and other management efforts.
Thank you for your continued support.
With warm regards,
Peter Pellerito
President and CEO
|
|
|
|
|
This case report describes the use of a miniaturized, disposable transesophageal echo probe (ClariTEE®, ImaCor Inc., Garden City, NY) to diagnose and monitor hemodynamic instability in a patient following surgery for aortic valve replacement and CABG X 3. Hemodynamic TEE (hTEE™) management allowed the physician to gauge fluid responsiveness in this patient with a moderately reduced EF of 30-35% preoperatively, CAD and COPD. hTEE also allowed the physician to follow the formation of a thrombus. This thrombus eventually became hemodynamically significant and the high chest tube output led to a return to the OR with removal of the clot accomplished and bleeding addressed. 
